Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Hot Flashes 3Pain 2post laminectomy syndrome 1Thyroid Nodule 1Thyroid Neoplasms 1Prostatic Neoplasms 1Peritoneal Cancer 1Pancreatic Neoplasms 1Neuroma 1Neuralgia 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Intestinal Diseases 1Inflammatory Bowel Diseases 1Ileus 1Hyperparathyroidism 1Graves Disease 1Goiter, Nodular 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Failed Back Surgery Syndrome 1Diverticulitis 1Digestive System Diseases 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Surveys and Questionnaires 1Oxycodone 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Malignant Neoplasms of Female Genital Organs × Bupivacaine × Clear all
NCT02740114 2021-10-18

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Terminated
105 enrolled 9 charts
GynecologicOther neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡